Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.76%68.42M | -10.45%16.48M | -15.00%16.62M | -13.71%16.05M | -4.21%19.27M | 8.17%76.67M | 9.96%18.4M | 3.10%19.55M | 17.92%18.6M | 4.20%20.11M |
| Cost of revenue | -15.07%40.85M | -30.91%8.12M | -7.23%10.54M | -10.46%11.03M | -11.87%11.17M | 8.06%48.1M | 14.82%11.75M | -1.98%11.36M | 20.99%12.32M | 1.30%12.67M |
| Gross profit | -3.52%27.56M | 25.73%8.36M | -25.77%6.08M | -20.08%5.02M | 8.83%8.1M | 8.36%28.57M | 2.31%6.65M | 11.07%8.2M | 12.33%6.29M | 9.54%7.44M |
| Operating expense | 18.02%23.97M | 0.86%6.82M | 5.16%6.1M | 22.41%7.06M | 101.46%3.99M | 68.74%20.31M | 13.78%6.76M | 7.91%5.8M | 2.56%5.77M | -64.03%1.98M |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | 4.18%12.5M | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | 1.89%7.43M | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | ---- | ---- | ---- | ---- | 7.71%5.07M | ---- | ---- | ---- | ---- |
| Other operating expenses | 7.23%27.43M | 0.39%7.55M | 4.68%6.35M | 25.81%7.5M | -0.03%6.04M | 63,928.94%25.58M | 16.29%7.52M | 8.09%6.06M | 2.02%5.96M | 0.07%6.04M |
| Total other operating income | -34.42%3.45M | -3.84%726K | -5.68%249K | 128.95%435K | -49.63%2.04M | --5.27M | 44.91%755K | 12.34%264K | -12.04%190K | 674.05%4.06M |
| Operating profit | -56.51%3.59M | 1,475.89%1.54M | -100.67%-16K | -495.16%-2.04M | -24.80%4.11M | -42.37%8.26M | -120.11%-112K | 19.57%2.4M | 1,820.00%516K | 325.49%5.46M |
| Net non-operating interest income (expenses) | 9.17%714K | -22.31%188K | -34.62%119K | 115.38%252K | 37.17%155K | 654K | 171.91%242K | 82.00%182K | -25.48%117K | 6.60%113K |
| Non-operating interest income | 9.17%714K | -22.31%188K | -34.62%119K | 115.38%252K | 37.17%155K | --654K | 171.91%242K | 82.00%182K | -25.48%117K | 6.60%113K |
| Non-operating interest expense | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -23.86%737K | 15.04%390K | 2.80%220K | -24.00%133K | -102.50%-6K | -25.05%968K | 17.30%339K | -51.69%214K | 26.81%175K | -42.99%240K |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 28.23%-7.22M | |||||||||
| Income before tax | -48.97%5.04M | 351.81%2.12M | -88.43%323K | -304.70%-1.65M | -26.81%4.25M | 77.81%9.88M | -49.84%469K | 9.62%2.79M | 204.91%808K | 221.10%5.81M |
| Income tax | -9.42%1.57M | 244.97%652K | -38.51%364K | -170.48%-234K | 27.23%785K | 27.39%1.73M | 34.04%189K | 30.11%592K | 80.43%332K | 6.75%617K |
| Net income | -57.36%3.48M | 423.93%1.47M | -101.86%-41K | -398.32%-1.42M | -33.22%3.47M | 94.12%8.15M | -64.74%280K | 5.16%2.2M | 487.65%476K | 321.67%5.2M |
| Net income continuous operations | -57.36%3.48M | 423.93%1.47M | -101.86%-41K | -398.32%-1.42M | -33.22%3.47M | 94.12%8.15M | -64.74%280K | 5.16%2.2M | 487.65%476K | 321.67%5.2M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 174.97%22K | 200.00%13K | -105.56%-1K | 100.00%2K | 300.00%8K |
| Net income attributable to the company | -57.25%3.48M | 449.44%1.47M | -101.86%-41K | -399.58%-1.42M | -33.12%3.47M | 93.97%8.13M | -66.91%267K | 6.13%2.2M | 492.50%474K | 321.71%5.19M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -57.25%3.48M | 449.44%1.47M | -101.86%-41K | -399.58%-1.42M | -33.12%3.47M | 93.97%8.13M | -66.91%267K | 6.13%2.2M | 492.50%474K | 321.71%5.19M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -57.26%0.0854 | 446.97%0.0361 | -101.85%-0.001 | -400.86%-0.0349 | -33.10%0.0853 | 93.98%0.1998 | -66.67%0.0066 | 6.29%0.0541 | 480.00%0.0116 | 322.19%0.1275 |
| Diluted earnings per share | -57.26%0.0854 | 446.97%0.0361 | -101.85%-0.001 | -400.86%-0.0349 | -33.10%0.0853 | 93.98%0.1998 | -66.67%0.0066 | 6.29%0.0541 | 480.00%0.0116 | 322.19%0.1275 |
| Dividend per share | 0.00%0.06 | 0 | 0 | 0 | 0.06 | 0.00%0.06 | 0 | 0 | 0.00%0.06 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.